
NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corporation(NMTC)内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。
SEC EDGAR · FMP · NMTC · 截至 2026年6月9日
活动摘要
买入笔数
3
P-Purchase only
卖出笔数
11
近12个月
买卖比
0.27
Buy/Sell (by trades)
整体情绪
NeuroOne Medical Technologies Corporation内部人在过去近12个月主要在卖出股份,卖出行为通常由预设的Rule 10b5-1计划驱动,不一定代表对公司的负面看法。
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
NMTC 季度内部人买卖趋势
NMTC 内幕交易卖出 · NMTC 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · NMTC CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
NMTC 高管卖出股份 · NMTC 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Apr 3, 2026 | Mills Jason Richard Director | Award | 41,929 | — | Form 4 |
| Apr 3, 2026 | MATHIESEN JEFFREY S Director | Award | 41,929 | — | Form 4 |
| Apr 3, 2026 | BUCKMAN PAUL Director | Award | 41,929 | — | Form 4 |
| Apr 3, 2026 | Andrle Edward Director | Award | 41,929 | — | Form 4 |
| Mar 30, 2026 | Christianson Mark Business Development Director | Sale | 15,363 | $11K | Form 4 |
| Mar 31, 2026 | Christianson Mark Business Development Director | Other | 253 | $197 | Form 4 |
| Mar 31, 2026 | Mertens Steve CTO | Other | 906 | $704 | Form 4 |
| Mar 31, 2026 | Rosa David A CEO and President · Director | Other | 2,458 | $2K | Form 4 |
| Mar 12, 2026 | Christianson Mark Business Development Director | Sale | 817 | $654 | Form 4 |
| Mar 13, 2026 | Christianson Mark Business Development Director | Sale | 100 | $80 | Form 4 |
| Mar 10, 2026 | Christianson Mark Business Development Director | Sale | 11,611 | $9K | Form 4 |
| Mar 11, 2026 | Christianson Mark Business Development Director | Sale | 2,109 | $2K | Form 4 |
| Mar 1, 2026 | Wambeke David J. Chief Business Officer | Purchase | 1,000,000 | $670K | Form 4 |
| Feb 18, 2026 | Mertens Steve CTO | Other | 7,376 | $5K | Form 4 |
| Feb 18, 2026 | Christianson Mark Business Development Director | Other | 1,812 | $1K | Form 4 |
| Feb 18, 2026 | Rosa David A CEO and President · Director | Other | 71,325 | $49K | Form 4 |
| Dec 31, 2025 | Mertens Steve CTO | Other | 906 | $687 | Form 4 |
| Dec 31, 2025 | Rosa David A CEO and President · Director | Other | 2,458 | $2K | Form 4 |
| Dec 31, 2025 | Christianson Mark Business Development Director | Other | 253 | $192 | Form 4 |
| Dec 18, 2025 | Mills Jason Richard Director | Award | 7,758 | — | Form 4 |
| Sep 30, 2025 | Mertens Steve CTO | Other | 906 | $805 | Form 4 |
| Sep 30, 2025 | Christianson Mark Business Development Director | Other | 253 | $225 | Form 4 |
| Sep 30, 2025 | Rosa David A CEO and President · Director | Other | 2,458 | $2K | Form 4 |
| Sep 5, 2025 | Christianson Mark Business Development Director | Sale | 30,000 | $22K | Form 4 |
| Jun 30, 2025 | Christianson Mark Business Development Director | Other | 253 | $172 | Form 4 |
Christianson Mark
Business Development Director
日期
Mar 30
股数
15,363
均价
$0.74
总金额
$11K
Christianson Mark
Business Development Director
日期
Mar 31
股数
253
均价
$0.78
总金额
$197
Christianson Mark
Business Development Director
日期
Mar 10
股数
11,611
均价
$0.80
总金额
$9K
Christianson Mark
Business Development Director
日期
Mar 11
股数
2,109
均价
$0.80
总金额
$2K
Wambeke David J.
Chief Business Officer
日期
Mar 1
股数
1,000,000
均价
$0.67
总金额
$670K
Christianson Mark
Business Development Director
日期
Feb 18
股数
1,812
均价
$0.68
总金额
$1K
Christianson Mark
Business Development Director
日期
Dec 31
股数
253
均价
$0.76
总金额
$192
Christianson Mark
Business Development Director
日期
Sep 30
股数
253
均价
$0.89
总金额
$225
Christianson Mark
Business Development Director
日期
Sep 5
股数
30,000
均价
$0.74
总金额
$22K
Christianson Mark
Business Development Director
日期
Jun 30
股数
253
均价
$0.68
总金额
$172
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 NMTC 内幕交易
NMTC 内幕交易
NeuroOne Medical Technologies Corporation(NMTC)内幕交易数据来源于公司内部人(包括Christianson Mark (Business Development Director), Mertens Steve (CTO), Rosa David A (CEO and President · Director))提交的SEC Form 4申报文件。过去12个月内,5位内部人向SEC提交了交易申报。NMTC内部人近期主要在卖出,这可能反映预设的10b5-1计划执行,而非方向性判断。
如需查看NeuroOne Medical Technologies Corporation机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →
常见问题
NMTC 内幕交易 · 5个问题NeuroOne Medical Technologies Corporation(NMTC)的内部人包括高管和董事,如Christianson Mark (Business Development Director), Mertens Steve (CTO), Rosa David A (CEO and President · Director)等。过去12个月内,5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026